$8.29
1.4921.91%
At close: Aug 25, 5:00 PM EST
$8.29
N/A
After Hours: 7:59 PM EST
Capricor Therapeutics Inc Stock News
CAPRNASDAQ
Latest Capricor Therapeutics Stock News | NASDAQ:CAPR | Benzinga
Get the latest news on Capricor Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Capricor Therapeutics performance
Categories: All
Tuesday, August 25, 2026
Monday, August 24, 2026
Friday, August 21, 2026
Monday, August 17, 2026
Friday, August 14, 2026
- 12 Health Care Stocks Moving In Friday's Intraday Session
- Capricor Therapeutics Remains Optimistic about Deramiocel FDA Approval
- This Capricor Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
- Capricor Therapeutics shares are trading high...PRO
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- Market-Moving News for August 14thPRO
- Cantor Fitzgerald Upgrades Capricor Therapeut...PRO
- Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
- Capricor Therapeutics (CAPR) Shares Soar Over 67% After Hours: Here's Why
Thursday, August 13, 2026
Saturday, August 01, 2026
Friday, July 31, 2026
Thursday, July 30, 2026
- Piper Sandler Downgrades Capricor Therapeutic...PRO
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Gold Surges 3%; Bristol-Myers Squibb Earnings Top Views
- Nasdaq Surges Over 600 Points; Microsoft Shares Jump After Upbeat Q4 Results
- Capricor Stock Tumbles After FDA Panel Rejects Evidence for Duchenne Cell Therapy
- Cantor Fitzgerald Downgrades Capricor Therape...PRO
- Capricor Therapeutics Announces FDA's Committ...PRO
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- HC Wainwright & Co. Downgrades Capricor Thera...PRO
- Trading Halt: Halt status updated at 7:00:00 AM ET: Quotation Resumption: News and Resumption Times
Wednesday, July 29, 2026
Monday, July 27, 2026
- QUICK SPARK: Capricor Stock Dives — 'Complete Fraud' Says Pharma Bro Martin Shkreli (UPDATED)
- Capricor Therapeutics Shares Dive Before Key Review as FDA Panel Challenges Data
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Crude Oil Falls Sharply; US Durable Goods Orders Increase 0.3% In June
- Capricor Says FDA Briefing Relies On Obsolete...PRO
- Dow Jumps Over 400 Points; AstraZeneca Shares Rise After Q2 Earnings
- Capricor Therapeutics Stock Plunges After FDA Releases Briefing Documents
- Capricor Therapeutics shares are trading lowe...PRO
- FDA Staff Review Says Data For Co's Duchenne ...PRO
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Everbright Digital, Kosmos Energy And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
